Advertisement

Topics

Ozanimod successful in clinical trials for multiple sclerosis

19:00 EST 8 Nov 2017 | AAAS

(Scripps Research Institute) Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod. Ozanimod was invented by scientists at The Scripps Research Institute (TSRI).

Original Article: Ozanimod successful in clinical trials for multiple sclerosis

NEXT ARTICLE

More From BioPortfolio on "Ozanimod successful in clinical trials for multiple sclerosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...